This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Extracorporeal Life Support Organization | |
|---|---|
| Name | Extracorporeal Life Support Organization |
| Abbreviation | ELSO |
| Formation | 1989 |
| Type | Nonprofit organization |
| Headquarters | Ann Arbor, Michigan |
| Region served | International |
| Membership | Centers and individuals |
Extracorporeal Life Support Organization is an international nonprofit consortium dedicated to the development, dissemination, and improvement of extracorporeal life support practices. Founded by clinicians with expertise in cardiothoracic surgery, critical care, and perfusion, the organization has become a central hub linking major institutions, specialized centers, and professional societies. It functions as a nexus between clinical programs, regulatory bodies, and research networks to standardize care for patients requiring extracorporeal membrane oxygenation and related technologies.
The organization emerged from collaborative efforts among practitioners at University of Michigan, Children's Hospital of Philadelphia, Boston Children's Hospital, and other leading centers during the late 1970s and 1980s, influenced by developments at Cleveland Clinic, Mayo Clinic, and Massachusetts General Hospital. Early milestones included workshops involving participants from National Institutes of Health, Food and Drug Administration, and specialist groups from American Thoracic Society, Society of Thoracic Surgeons, and American Heart Association. Over subsequent decades, the organization expanded alongside technological innovations from companies such as Medtronic, Maquet, and Getinge, and clinical advances documented by investigators at Johns Hopkins Hospital, Stanford Health Care, and UCSF Medical Center. High-profile global events, including the H1N1 influenza pandemic and the COVID-19 pandemic, catalyzed growth in registry participation and international collaboration with partners like World Health Organization and national agencies in United Kingdom, Australia, Canada, and Japan.
Governance is structured through a governing board composed of clinicians and administrators drawn from accredited centers including Children's National Hospital, Royal Children's Hospital (Melbourne), and Great Ormond Street Hospital. Advisory committees interface with international societies such as European Society for Intensive Care Medicine, International Pediatric and Congenital Cardiac Society, and Society of Critical Care Medicine, while legal and ethic consultation has involved entities like American Bar Association. Financial oversight and philanthropic engagement have connected the organization with foundations and benefactors tied to Gates Foundation and academic endowments at institutions such as Yale School of Medicine and Columbia University Irving Medical Center. Strategic partnerships with regulatory authorities including European Medicines Agency and national health services inform policy alignment and device evaluation.
Membership encompasses multidisciplinary teams from tertiary centers, community hospitals, and standalone programs, with registered units from Royal Papworth Hospital, Toronto General Hospital, and Karolinska University Hospital. Accreditation processes were developed in concert with professional bodies like American Academy of Pediatrics and Association of Anaesthetists. The organization’s accreditation criteria reference standards applied at centers such as UCLA Health and NewYork-Presbyterian Hospital, and incorporate external review by panels including representatives from British Paediatric Intensive Care Society and the Japan Society of Intensive Care Medicine.
Clinical guidance produced by the organization synthesizes evidence and expert consensus, drawing on research from teams at Vanderbilt University Medical Center, Hopkins Children's, and Children's Hospital Los Angeles. Guidelines address indications, cannulation, anticoagulation, and weaning, integrating methodologies referenced by Cochrane Collaboration reviews and position statements from American College of Chest Physicians. Standards align with device labeling from manufacturers like Abbott Laboratories and Terumo Corporation and with infection control practices endorsed by Centers for Disease Control and Prevention and Public Health England.
The registry curates patient-level data submitted by centers worldwide including scholarly contributions from Harvard Medical School, Karolinska Institutet, and Imperial College London. Analyses have informed outcomes research, quality improvement, and randomized trials in collaboration with networks such as National Institutes of Health consortia and multicenter groups like PALISI Network. Reports have been cited in publications from The Lancet, New England Journal of Medicine, and JAMA, and have supported device evaluation studies involving Boston Scientific and academic investigators at University of Toronto.
Educational initiatives include simulation curricula, workshops, and certification pathways developed with input from American Board of Pediatrics, Royal College of Physicians, and university training programs at University of Oxford, University of Cambridge, and McGill University. Training collaboratives partner with societies such as European Society for Paediatric Research and Latin American Society of Pediatric Intensive Care to expand competency-based education for perfusionists, intensivists, and surgeons, referencing pedagogical frameworks from Association of American Medical Colleges.
Annual meetings convene clinicians, researchers, and industry representatives at venues associated with institutions like Hilton Hotels and academic conference centers used by Massachusetts General Hospital and Johns Hopkins University. The organization also facilitates regional symposia in collaboration with Asia-Pacific Society of Cardiology, African Paediatric Fellowship Programme, and national groups in Germany, France, and Brazil. Public outreach and advocacy efforts engage with patient advocacy organizations such as American Heart Association and March of Dimes to raise awareness of extracorporeal support therapies.
Category:Medical organizations